| 101692-2 | Maximum heart rate |
| 103205-1 | Mean heart rate |
| 103209-3 | Mean oxygen saturation |
| 103211-9 | Number of awakenings |
| 103213-5 | Duration in bed |
| 103214-3 | Duration of out of bed |
| 103215-0 | Wake time after sleep onset |
| 103216-8 | Number of times getting out of bed |
| 103217-6 | Mean respiratory rate |
| 103218-4 | Minimum respiratory rate |
| 103219-2 | Maximum respiratory rate |
| 103221-8 | Number of snoring episodes |
| 103222-6 | Heart rate.minimum |
| 103224-2 | Duration of getting out of bed |
| 105992-2 | Alcoholic drinks per week |
| 105999-7 | Drinks of water per day |
| 106299-1 | How much time is usually spent on screens |
| 107603-3 | Lymphocyte proliferation stimulated (candida albicans in blood) |
| 107604-1 | Lymphocyte proliferation stimulated (tetanus toxoid in blood) |
| 107605-8 | Lymphocyte proliferation stimulated (tuberculin in blood) |
| 111763-9 | Sampling frequency |
| 11286-2 | Alcohol binge episodes per month - Reported |
| 11287-0 | Alcoholic drinks per drinking day - Reported |
| 11291-2 | Respiratory rate at First encounter |
| 11328-2 | Heart rate at First encounter |
| 11948-7 | Fetal Heart rate US |
| 18407-7 | Leukocytes in 12 hour Urine sediment (light microscopy) |
| 19828-3 | Breaths maximum setting Ventilator |
| 19829-1 | Breaths maximum setting Ventilator alarm |
| 19830-9 | Breaths maximum setting Apnea monitor |
| 19831-7 | Breath rate minimum setting Ventilator |
| 19832-5 | Breath rate minimum setting Ventilator alarm |
| 19833-3 | Breath rate minimum setting Apnea monitor |
| 19834-1 | Breath rate setting Ventilator |
| 19835-8 | Breath rate setting Ventilator synchronized intermittent mandatory |
| 19836-6 | Breath rate setting Intermittent mandatory ventilator |
| 19837-4 | Breath rate setting Neonatal ventilator |
| 19838-2 | Sigh rate setting Ventilator |
| 19839-0 | Breath rate spontaneous --on ventilator |
| 19840-8 | Breath rate spontaneous and mechanical --on ventilator |
| 19841-6 | Respiratory rate (spirometry --at maximum voluntary ventilation) |
| 19842-4 | Respiratory rate --at maximum voluntary ventilation |
| 19946-3 | Maximum heart rate setting Apnea Monitor Alarm |
| 19947-1 | Heart rate minimum setting Apnea Monitor Alarm |
| 33438-3 | Breath rate mechanical --on ventilator |
| 40441-8 | Respiratory rate --post exercise |
| 40442-6 | Heart rate --post exercise |
| 40443-4 | Heart rate --resting |
| 40586-0 | Heart beat^pre exercise: NRat: Pt: XXX: Qn: Oximetry |
| 40587-8 | Heart rate (oximetry --post exercise) |
| 41920-0 | Heart rate 1 hour mean |
| 41921-8 | Heart rate 8 hour mean |
| 41922-6 | Heart rate 10 hour mean |
| 41923-4 | Heart rate 12 hour mean |
| 41924-2 | Heart rate 24 hour mean |
| 41941-6 | Current medication, Basal rate |
| 41950-7 | Number of steps in 24 hour Measured |
| 41951-5 | Number of steps in 24 hour mean Measured |
| 41952-3 | Number of steps in 1 week Measured |
| 44609-6 | Heart rate Episode maximum (oximetry) |
| 44610-4 | Heart rate Episode minimum (oximetry) |
| 44611-2 | Heart rate Episode mean (oximetry) |
| 44940-5 | Alcoholic drinks per week - Reported |
| 45360-5 | Lymphocyte proliferation stimulated (0.125 ug pokeweed mitogen in blood) |
| 45361-3 | Lymphocyte proliferation stimulated (0.25 ug pokeweed mitogen in blood) |
| 45362-1 | Lymphocyte proliferation stimulated (0.50 ug pokeweed mitogen in blood) |
| 45363-9 | Lymphocyte proliferation stimulated (1.0 ug phytohemagglutinin in blood) |
| 45365-4 | Lymphocyte proliferation stimulated (10 ug concanavalin a in blood) |
| 45366-2 | Lymphocyte proliferation stimulated (2.0 ug phytohemagglutinin in blood) |
| 45367-0 | Lymphocyte proliferation stimulated (20 ug concanavalin a in blood) |
| 45368-8 | Lymphocyte proliferation stimulated (5 ug concanavalin a in blood) |
| 45369-6 | Lymphocyte proliferation stimulated (0.5 ug phytohemagglutinin in blood) |
| 45558-4 | Frequency of wandering (qualitative) |
| 45560-0 | Frequency of verbally abusive behavioral symptoms |
| 45562-6 | Frequency of physically abusive behavioral symptoms |
| 45564-2 | Frequency of socially inappropriate or disruptive behavioral symptoms |
| 45566-7 | Frequency of resists care |
| 45710-1 | Pain frequency (qualitative) |
| 45760-6 | Number of days with at least 15 minutes of speech language pathology and audiology services in the last 7 days |
| 45762-2 | Number of days with at least 15 minutes of occupational therapy in the last 7 days |
| 45764-8 | Number of days with at least 15 minutes of physical therapy in the last 7 days |
| 45766-3 | Number of days with at least 15 minutes of respiratory therapy in the last 7 days |
| 45768-9 | Number of days with at least 15 minutes of psychological therapy (any licensed mental health professional in the last 7 days) |
| 45876-0 | Number of emergency room visits in last 90 days |
| 45877-8 | Number of physician visits in last 14 days |
| 49921-0 | Lymphocyte proliferation stimulated (concanavalin a in blood) |
| 49922-8 | Lymphocyte proliferation stimulated (phytohemagglutinin in blood) |
| 49923-6 | Lymphocyte proliferation stimulated (pokeweed mitogen in blood) |
| 52566-7 | Maximum suctioning frequency per hour during stay |
| 52810-9 | Current medication, Frequency |
| 54682-0 | Physical behavioral symptoms directed toward others during assessment period (qualitative) |
| 54683-8 | Verbal behavioral symptoms directed toward others during assessment period (qualitative) |
| 54684-6 | Other behavioral symptoms not directed toward others during assessment period (qualitative) |
| 54692-9 | Rejection of care - presence and frequency in last 7 days (qualitative) |
| 54693-7 | Wandering - presence and frequency in last 7 days (qualitative) |
| 54982-4 | Number of days injectable substances received in last 7 days or since admission/reentry if less than 7 days |
| 55036-8 | Number of days with at least 15 minutes of recreational and music therapy in last 7 days |
| 55040-0 | Number of days physician examined the patient in last 14 days |
| 55041-8 | Number of days physician orders changed in last 14 days |
| 55213-3 | Number of male sexual partners in 6 months before symptom onset |